Analysts say these ASX 200 shares can rise 30% to 50%

Analysts think these shares could be good options for investors next year.

| More on:

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

If you're on the lookout for some big returns for your portfolio in 2024, then look no further.

That's because listed below are four ASX 200 shares that analysts are tipping to rise between 30% and 55%.

Here's what you need to know about these shares:

A young man wearing a black and white striped t-shirt looks surprised.

Image source: Getty Images

Flight Centre Travel Group Ltd (ASX: FLT)

Over at Morgans, its analysts think that Flight Centre's shares could provide big returns for investors in 2024.

The broker currently has an add rating and a $26 price target on the travel agent's shares. This suggests a potential upside of 31% from current levels between now and this time next year.

Pilbara Minerals Ltd (ASX: PLS)

Morgans is also still very positive on this mining giant despite the significant lithium price weakness in 2023.

It currently has an add rating and a $5 price target on the lithium miner's shares. This would mean an upside of 30% for investors if Morgans is spot on with its recommendation for Pilbara Minerals.

Qantas Airways Limited (ASX: QAN)

Goldman Sachs believes that Qantas is an undervalued ASX 200 share. The broker currently has a conviction buy rating and a $8.25 price target on the airline operator's shares.

Based on the current Qantas share price of $5.36, this implies a potential upside of 54% for investors over the next 12 months.

ResMed Inc. (ASX: RMD)

Despite a recent rebound following an Ozempic-related selloff, analysts at Macquarie believe that ResMed's shares are still very cheap.

Its analysts recently put an outperform rating and $33.40 price target on the sleep treatment company's shares. If Macquarie is on the money with its recommendation, this would mean a sizeable return of 31% for investors in 2024.

Motley Fool contributor James Mickleboro has positions in ResMed. The Motley Fool Australia's parent company Motley Fool Holdings Inc. has positions in and has recommended Goldman Sachs Group, Macquarie Group, and ResMed. The Motley Fool Australia has positions in and has recommended Macquarie Group and ResMed. The Motley Fool Australia has recommended Flight Centre Travel Group. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

More on Broker Notes

A man holding a cup of coffee puts his thumb up and smiles with a laptop open.
Broker Notes

Top brokers name 3 ASX shares to buy next week

Brokers gave buy ratings to these ASX shares last week. Why are they bullish?

Read more »

A man in a business suit rides a graphic image of an arrow that is rebounding on a graph.
Broker Notes

Down 43% this week, are Cochlear shares now the best bargain buy of the year?

A leading analyst believes the historic selloff in Cochlear shares could present a unique buying opportunity.

Read more »

A smiling woman at a hardware shop selects paint colours from a wall display.
Broker Notes

Wesfarmers shares: Buy, hold or sell?

A leading analyst delivers his verdict on Wesfarmers shares.

Read more »

Businessman working and using Digital Tablet new business project finance investment at coffee cafe.
Broker Notes

Buy, hold, sell: Cochlear, CSL, and DroneShield shares

Are these hugely popular shares in the buy zone or not? Let's find out.

Read more »

Man with rocket wings which have flames coming out of them.
Broker Notes

These ASX 200 shares could rise ~40% to 80%

Brokers are predicting big returns for these top shares. Here's what you need to know.

Read more »

Person pointing at an increasing blue graph which represents a rising share price.
Broker Notes

2 ASX 200 stocks that could rise 50%

Morgans thinks the market is undervaluing these shares.

Read more »

Contented looking man leans back in his chair at his desk and smiles.
Broker Notes

Brokers name 3 ASX shares to buy right now

Here's why brokers are feeling bullish about these three shares this week.

Read more »

Dollar sign in yellow with a red falling arrow in front of a graph, symbolising a falling share price.
Broker Notes

6 ASX 200 shares downgraded by brokers this week

Brokers have reduced their ratings on TechnologyOne, Macquarie, 4DMedical, and others this week.

Read more »